« Back to Record
Da Costa Pereira Pinto, A. C., de Azambuja, E., & Piccart-Gebhart, M. (2013). How long is enough-optimal timing of anti-HER2/neu therapy in the adjuvant setting in early breast cancer. Breast Care, 8(4), 264-269. doi:10.1159/000354697
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/168477



